Variant report
Variant | esv3502424 |
---|---|
Chromosome Location | chr10:110915776-110920303 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:110909632..110912318-chr10:110918760..110920466,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536738584 | chr10:110915779-110915780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556389933 | chr10:110915790-110915791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2147283 | chr10:110915808-110915809 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs535615612 | chr10:110915809-110915810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576216484 | chr10:110915816-110915817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183066845 | chr10:110915820-110915821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376961794 | chr10:110915852-110915853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs71486069 | chr10:110915870-110915871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187124102 | chr10:110915877-110915878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs398046238 | chr10:110915878-110915879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2147284 | chr10:110915892-110915893 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs558326321 | chr10:110915930-110915931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557848595 | chr10:110915936-110915937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs578076642 | chr10:110915941-110915942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115622090 | chr10:110915970-110915971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563725338 | chr10:110915971-110915972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2147285 | chr10:110916028-110916029 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs191936613 | chr10:110916031-110916032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559713186 | chr10:110916052-110916053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182186790 | chr10:110916062-110916063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372849172 | chr10:110916102-110916103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551397203 | chr10:110916161-110916162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150896950 | chr10:110916162-110916163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530481005 | chr10:110916215-110916216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550272545 | chr10:110916252-110916253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187993722 | chr10:110916271-110916272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535676563 | chr10:110916303-110916304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113861988 | chr10:110916327-110916328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11194430 | chr10:110916329-110916330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs61883172 | chr10:110916384-110916385 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs185562344 | chr10:110916389-110916390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577960538 | chr10:110916422-110916423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537400711 | chr10:110916485-110916486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557504263 | chr10:110916530-110916531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574160810 | chr10:110916554-110916555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs199564969 | chr10:110916555-110916556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542878329 | chr10:110916561-110916562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111526185 | chr10:110916562-110916563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79899666 | chr10:110916565-110916566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370681781 | chr10:110916602-110916603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111772453 | chr10:110916656-110916657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550617174 | chr10:110916661-110916662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139470907 | chr10:110916663-110916664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs74781690 | chr10:110916691-110916692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530440694 | chr10:110916696-110916697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550135166 | chr10:110916831-110916832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111598318 | chr10:110916866-110916867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146702455 | chr10:110916871-110916872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549203742 | chr10:110916923-110916924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551747310 | chr10:110916944-110916945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Paraganglioma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
renal hypoplasia | 20603712 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Cornelia de Lange syndrome | 24599119 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 16397240 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Chronic lymphocytic leukemia | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:110915600-110916000 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr10:110916000-110916400 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr10:110916400-110917400 | Enhancers | Placenta Amnion | Placenta Amnion |
4 | chr10:110916600-110917000 | Enhancers | Fetal Kidney | kidney |
5 | chr10:110916600-110917200 | Enhancers | Placenta | Placenta |
6 | chr10:110919400-110919600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr10:110920200-110920400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |